Lantheus
LNTH
Collegium Pharmaceutical
COLL
Constellation Brands
STZ
Halozyme Therapeutics
HALO
AIRPORTS OF THAILAND PUBLIC CO UNSP ADR EACH REP 10 ORD SHS
AIPUY
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -25.39%204.98M | 15.42%84.64M | -112.16%-9M | -32.41%67.4M | 123.83%61.94M | 121.16%274.75M | 10.57%73.34M | 73.06%74.02M | 146.53%99.72M | 209.31%27.67M |
Net income from continuing operations | 43.68%69.19M | -60.75%12.54M | -54.76%9.34M | 50.73%19.61M | 259.03%27.71M | 292.60%48.16M | 543.67%31.94M | 4,415.10%20.63M | 350.57%13.01M | -33.34%-17.43M |
Operating gains losses | -51.80%11.33M | --0 | --4.15M | ---- | ---- | --23.5M | --0 | --0 | --0 | --23.5M |
Depreciation and amortization | 13.34%169.16M | 59.35%56.51M | 12.37%41.75M | -7.54%35.47M | -7.44%35.43M | 7.43%149.26M | -17.73%35.46M | -2.33%37.15M | 0.53%38.36M | 94.94%38.28M |
Deferred tax | -1,145.42%-26.81M | -2,904.73%-10.16M | -670.79%-8.73M | -452.36%-3.51M | -9,491.30%-4.41M | 74.34%-2.15M | 68.65%-338K | -154.03%-1.13M | 81.14%-636K | 99.24%-46K |
Other non cash items | -19.56%6.72M | -11.23%1.72M | -20.25%1.66M | -26.52%1.58M | -19.43%1.76M | -1.97%8.36M | -14.87%1.94M | -12.61%2.08M | -22.91%2.15M | 103.73%2.18M |
Change In working capital | -352.99%-54.98M | 899.67%16.81M | -824.44%-63.95M | -105.56%-2.22M | 77.41%-5.62M | 270.94%21.73M | -108.93%-2.1M | 258.18%8.83M | 1,580.69%39.87M | 24.78%-24.86M |
-Change in receivables | -222.82%-4.41M | -95.44%106K | 98.68%-190K | -178.66%-9.16M | 21.01%4.83M | 116.50%3.59M | -81.06%2.33M | -783.73%-14.37M | 137.38%11.65M | 179.76%3.99M |
-Change in inventory | -1.71%13.93M | 37.87%2.47M | 186.25%6.99M | -50.30%3.41M | -92.24%1.06M | -70.65%14.17M | -90.12%1.79M | -161.74%-8.1M | -58.81%6.87M | 4,023.03%13.61M |
-Change in prepaid assets | -1,077.76%-14.07M | -239.44%-1.95M | -124.23%-434K | -661.81%-11.51M | 25.63%-177K | 131.24%1.44M | 124.93%1.4M | 137.85%1.79M | -249.77%-1.51M | -135.16%-238K |
-Change in payables and accrued expense | -2,093.71%-50.42M | 312.38%16.18M | -338.29%-70.32M | -34.20%15.04M | 73.17%-11.33M | 107.31%2.53M | -494.69%-7.62M | 236.92%29.51M | 32.28%22.86M | -45.33%-42.22M |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -25.39%204.98M | 15.42%84.64M | -112.16%-9M | -32.41%67.4M | 123.83%61.94M | 121.16%274.75M | 10.57%73.34M | 73.06%74.02M | 146.53%99.72M | 209.31%27.67M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -306.37%-287.76M | 53.13%-11.76M | -6,413.95%-248.96M | 78.65%-8.91M | -10,200.00%-18.13M | 87.66%-70.81M | -2,569.89%-25.1M | -3,282.30%-3.82M | -8,949.24%-41.72M | 99.97%-176K |
Net PPE purchase and sale | -258.35%-1.65M | -247.56%-570K | -275.38%-244K | -382.14%-270K | -222.73%-568K | 71.58%-461K | 82.55%-164K | 42.48%-65K | 87.85%-56K | -62.96%-176K |
Net business purchase and sale | ---267.54M | --0 | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
Net investment purchase and sale | 73.61%-18.57M | 55.11%-11.19M | 600.90%18.82M | 79.27%-8.64M | ---17.56M | ---70.35M | ---24.93M | ---3.76M | ---41.66M | --0 |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | -306.37%-287.76M | 53.13%-11.76M | -6,413.95%-248.96M | 78.65%-8.91M | -10,200.00%-18.13M | 87.66%-70.81M | -2,569.89%-25.1M | -3,282.30%-3.82M | -8,949.24%-41.72M | 99.97%-176K |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 56.77%-60.6M | 39.14%-41.28M | 256.19%149.03M | -152.47%-114.21M | -179.28%-54.15M | -132.10%-140.18M | -162.66%-67.83M | -205.30%-95.41M | -88.75%-45.24M | -86.81%68.3M |
Net issuance payments of debt | 111.41%7.52M | 64.77%-16.15M | 424.10%148.55M | -70.86%-79.05M | -163.64%-45.83M | -114.89%-65.92M | -83.33%-45.83M | -83.34%-45.83M | -85.07%-46.27M | -86.09%72.02M |
Net common stock issuance | 19.97%-60.03M | -0.10%-25.03M | --0 | ---- | ---- | -433.31%-75M | -227.18%-25M | ---50M | ---- | ---- |
Proceeds from stock option exercised by employees | 21.67%11.07M | -94.66%173K | 4.55%620K | 357.15%5.72M | 13.54%4.56M | -25.08%9.1M | -52.79%3.24M | 114.86%593K | -19.03%1.25M | 15.96%4.02M |
Net other financing activities | -129.28%-19.17M | -19.74%-279K | 17.44%-142K | -2,570.45%-5.88M | -66.42%-12.87M | -106.75%-8.36M | -417.78%-233K | -62.26%-172K | 56.95%-220K | -128.74%-7.74M |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | 56.77%-60.6M | 39.14%-41.28M | 256.19%149.03M | -152.47%-114.21M | -179.28%-54.15M | -132.10%-140.18M | -162.66%-67.83M | -205.30%-95.41M | -88.75%-45.24M | -86.81%68.3M |
Net cash flow | ||||||||||
Beginning cash position | 36.18%239.99M | -74.96%65.01M | -38.92%173.94M | -15.58%229.66M | 36.18%239.99M | -6.74%176.24M | 89.93%259.58M | 127.35%284.8M | 149.01%272.03M | -6.74%176.24M |
Current changes in cash | -324.88%-143.38M | 261.37%31.61M | -331.99%-108.93M | -536.34%-55.72M | -110.79%-10.34M | 600.54%63.76M | -149.50%-19.59M | -321.12%-25.22M | -20.31%12.77M | 220.15%95.79M |
End cash Position | -59.74%96.61M | -59.74%96.61M | -74.96%65.01M | -38.92%173.94M | -15.58%229.66M | 36.18%239.99M | 36.18%239.99M | 89.93%259.58M | 127.35%284.8M | 149.01%272.03M |
Free cash flow | -25.87%203.33M | 14.90%84.07M | -112.50%-9.24M | -32.65%67.13M | 123.20%61.37M | 123.71%274.29M | 11.91%73.17M | 73.37%73.95M | 149.23%99.67M | 208.15%27.5M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |